Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients.

Authors Rawson JB, Manno M, Mrkonjic M, et al.
Citation Carcinogenesis. 2011 May;32(5):741-7.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/21304055/
PMCID PMC3140140

Read this next

On combining family-based and population-based case-control data in association studies.